文献速递神经核医学肿瘤 PET/CT放射性药物与辐射防护

动态[18F]-AV-1451灌注PET与[18F]-FDG PET神经元低代谢的多模态相关性研究

Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-10-12

20例疑似神经退行性病变患者分别接受FDG PET和早期动态AV-1451 PET(注射200 MBq后采集10个1分钟帧),早期AV-1451灌注缺损与FDG代谢缺损在区域模式和范围上高度可比,最佳时间窗为60至360秒(r=0.86),结论认为AV-1451灌注成像可作为评估神经元功能障碍的有效生物标志物,常规采集早期AV-1451图像可减少辐射暴露和检查复杂性,从而省去额外的FDG PET。

要点

  • 早期AV-1451灌注缺损与FDG代谢缺损在区域模式和范围上高度可比。
  • 最佳时间窗为60至360秒,体素水平汇总相关系数r=0.86。
  • 区域分析相关系数从r=0.96(皮层下灰质)到0.83(额叶)。

核心结论

  • 作者认为AV-1451灌注成像是评估神经退行性疾病神经元功能障碍的有效生物标志物。
  • 作者认为常规采集早期AV-1451图像可显著减少辐射暴露和诊断流程复杂性,省去额外的FDG PET。

研究设计与样本

  • 20例疑似神经退行性病变患者接受FDG PET和早期动态AV-1451 PET成像。
  • 注射200 MBq AV-1451后采集10个1分钟时间帧,FDG图像按临床方案于不同日期采集。
  • 早期AV-1451时间帧与个体FDG扫描配准并空间标准化,在个体内水平计算每个可能时间窗的体素水平跨模态相关性,汇总相关性最高的时间窗视为最佳。
  • 分别从FDG和早期AV-1451图像生成Z变换偏差图(ZMs),与健康对照FDG图像比较。

主要发现

  • 灌注缺损的区域模式和范围与代谢缺损高度可比。
  • 最佳结果见于60至360秒时间窗,r=0.86。
  • 区域分析中相关性强度从r=0.96(皮层下灰质)到0.83(额叶)。
  • 早期AV-1451与FDG图像的ZMs高度相似。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Cerebral glucose metabolism measured with [18F]-FDG PET is a well established marker of neuronal dysfunction in neurodegeneration. The tau-protein tracer [18F]-AV-1451 PET is currently under evaluation and shows promising results. Here, we assess the feasibility of early perfusion imaging with AV-1451 as a substite for FDG PET in assessing neuronal injury. METHODS: Twenty patients with suspected neurodegeneration underwent FDG and early phase AV-1451 PET imaging. Ten one-minute timeframes were acquired after application of 200 MBq AV-1451. FDG images were acquired on a different date according to clinical protocol. Early AV-1451 timeframes were coregistered to individual FDG-scans and spatially normalized. Voxel-wise intermodal correlations were calculated on within-subject level for every possible time window. The window with highest pooled correlation was considered optimal. Z-transformed deviation maps (ZMs) were created from both FDG and early AV-1451 images, comparing against FDG images of healthy controls. RESULTS: Regional patterns and extent of perfusion deficits were highly comparable to metabolic deficits. Best results were observed in a time window from 60 to 360 s (r = 0.86). Correlation strength ranged from r = 0.96 (subcortical gray matter) to 0.83 (frontal lobe) in regional analysis. ZMs of early AV-1451 and FDG images were highly similar. CONCLUSION: Perfusion imaging with AV-1451 is a valid biomarker for assessment of neuronal dysfunction in neurodegenerative diseases. Radiation exposure and complexity of the diagnostic workup could be reduced significantly by routine acquisition of early AV-1451 images, sparing additional FDG PET.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Hammes J, Leuwer I, Bischof GN, et al. Multimodal correlation of dynamic [18F]-AV-1451 perfusion PET and neuronal hypometabolism in [18F]-FDG PET. Eur J Nucl Med Mol Imaging. 2017. PMID: 29026951. doi:10.1007/s00259-017-3840-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。